ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANALYTICAL APPROACH;
ARTICLE;
ATTITUDE TO HEALTH;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROL GROUP;
CONTROLLED CLINICAL TRIAL;
DRUG LEGISLATION;
FEMALE;
HEALTH CARE AND PUBLIC HEALTH;
HEALTH CARE DELIVERY;
HUMAN;
HUMAN EXPERIMENT;
MALE;
MEDICAL ETHICS;
METHODOLOGY;
MISCELLANEOUS NAMED GROUPS;
MORALITY;
PATERNAL BEHAVIOR;
PATERNALISM;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PERSONAL AUTONOMY;
PREDICTION AND FORECASTING;
PROFESSIONAL STANDARD;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL;
RESEARCH SUBJECT;
STANDARD;
UNITED STATES;
VULNERABLE POPULATION;
ANALYTICAL APPROACH;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
HEALTH CARE AND PUBLIC HEALTH;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
CLINICAL PROTOCOLS;
CONTROL GROUPS;
DRUGS, INVESTIGATIONAL;
ETHICS COMMITTEES, RESEARCH;
ETHICS, MEDICAL;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
LEGISLATION, DRUG;
MALE;
MORAL OBLIGATIONS;
PATERNAL BEHAVIOR;
PATERNALISM;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PERSONAL AUTONOMY;
PERSONS;
PLACEBOS;
PREDICTIVE VALUE OF TESTS;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
RESEARCH SUBJECTS;
THERAPEUTIC HUMAN EXPERIMENTATION;
UNITED STATES;
VULNERABLE POPULATIONS;
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987;317:185-91; Richman DD, Fischl MA. Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987;314:192-7.
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987;317:185-91; Richman DD, Fischl MA. Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987;314:192-7.
A review of AZT multi center trial-data obtained under the Freedom of Information Act by Project Inform and ACT Up
Sonnabend J. A review of AZT multi center trial-data obtained under the Freedom of Information Act by Project Inform and ACT Up. AIDS Forum 1989;1(1):9-15.
Antiretroviral therapy for adult HIV-infected patients - Recommendations from a state-of-the-art conference
Sande MA, Arpener CCJ, Obiss CG, et al. Antiretroviral therapy for adult HIV-infected patients - recommendations from a state-of-the-art conference. Journal of the American Medical Association 1993;270:2583-9.
The estimate is conservative, based on TAG's Summary of US Research Budget. When one adds the costs of the many industry trials, the effort of the MRC in Britain, INSERM in France, the Australian European Cooperative Group, etc., the amount is probably double this figure
The estimate is conservative, based on TAG's Summary of US Research Budget. When one adds the costs of the many industry trials, the effort of the MRC in Britain, INSERM in France, the Australian European Cooperative Group, etc., the amount is probably double this figure.
11
0027365682
On stopping a trial before its time
[Anonymous]. On stopping a trial before its time. The Lancet 1993;342:1311-2.
Pneumocystis carinii pneumonia is a common opportunistic infection in PWAs and the cause of most AIDS-related deaths
Pneumocystis carinii pneumonia is a common opportunistic infection in PWAs and the cause of most AIDS-related deaths.
15
0037827867
New York: Penguin
Nussbaum B. Good Intentions. How Big Business and the Medical Establishment Are Corrupting the Fight Against AIDS, Alzheimer's, Cancer and More. New York: Penguin, 1991.
